DENTSPLY SIRONA (XRAY) Expected to Announce Earnings on Thursday

DENTSPLY SIRONA (NASDAQ:XRAY) is expected to release its Q3 2025 results before the market opens on Thursday, November 6th. Analysts expect DENTSPLY SIRONA to post earnings of $0.45 per share and revenue of $900.3320 million for the quarter. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS.Interested persons can find conference call details on the company’s upcoming Q3 2025 earningreport page for the latest details on the call scheduled for Thursday, November 6, 2025 at 8:30 AM ET.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.50 by $0.02. The firm had revenue of $936.00 million during the quarter, compared to analyst estimates of $929.67 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.DENTSPLY SIRONA’s quarterly revenue was down 4.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.49 earnings per share. On average, analysts expect DENTSPLY SIRONA to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

DENTSPLY SIRONA Stock Down 0.5%

DENTSPLY SIRONA stock opened at $12.55 on Tuesday. The business has a fifty day moving average of $13.18 and a two-hundred day moving average of $14.52. The company has a quick ratio of 1.11, a current ratio of 1.69 and a debt-to-equity ratio of 1.13. The firm has a market cap of $2.50 billion, a P/E ratio of -2.65, a P/E/G ratio of 0.81 and a beta of 0.96. DENTSPLY SIRONA has a twelve month low of $11.69 and a twelve month high of $24.86.

Hedge Funds Weigh In On DENTSPLY SIRONA

A number of large investors have recently made changes to their positions in XRAY. Empowered Funds LLC increased its position in shares of DENTSPLY SIRONA by 8.8% in the 1st quarter. Empowered Funds LLC now owns 16,324 shares of the medical instruments supplier’s stock valued at $244,000 after acquiring an additional 1,320 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in shares of DENTSPLY SIRONA in the 1st quarter valued at $26,000. Brevan Howard Capital Management LP increased its position in shares of DENTSPLY SIRONA by 9.9% in the 2nd quarter. Brevan Howard Capital Management LP now owns 20,002 shares of the medical instruments supplier’s stock valued at $318,000 after acquiring an additional 1,800 shares during the period. Treasurer of the State of North Carolina increased its position in shares of DENTSPLY SIRONA by 2.6% in the 2nd quarter. Treasurer of the State of North Carolina now owns 93,017 shares of the medical instruments supplier’s stock valued at $1,477,000 after acquiring an additional 2,353 shares during the period. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main increased its position in shares of DENTSPLY SIRONA by 4.0% in the 2nd quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 74,920 shares of the medical instruments supplier’s stock valued at $1,190,000 after acquiring an additional 2,872 shares during the period. 95.70% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on XRAY. Stifel Nicolaus lowered their target price on DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating for the company in a report on Friday, August 8th. Barrington Research restated an “outperform” rating and set a $18.00 target price on shares of DENTSPLY SIRONA in a report on Wednesday, October 29th. Needham & Company LLC restated a “hold” rating on shares of DENTSPLY SIRONA in a report on Friday, September 26th. Evercore ISI lowered their target price on DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating for the company in a report on Wednesday, October 8th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of DENTSPLY SIRONA in a report on Wednesday, October 8th. Two equities research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $17.91.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.